Biote CEO Bret Christensen, board members buy 260,000 shares of common stock

Biote (BTMD) announced that several members of its board of directors, along with CEO Bret Christensen, have made open market purchases of Biote’s common stock, acquiring an aggregate of approximately 260,000 shares. Marc Beer, Biote executive chairman, said, “These share purchases underscore the collective confidence of Biote’s Board members and CEO Bret Christensen in the Company’s business strategy and long-term outlook. The board is very confident in Bret’s ability to make decisive and material changes at Biote to grow our business. With his deep expertise spanning the diagnostic, therapeutic and medical device health care sectors, we believe Bret is exceptionally qualified to lead Biote’s next level of business growth.”